Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development and application of genetic ancestry reconstruction methods to study diversity of patient-derived models in the NCI PDXNet Consortium

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.24.513591Source: DataRank Database

Development and application of genetic ancestry reconstruction methods to study diversity of patient-derived models in the NCI PDXNet Consortium is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)OA: greenTopics (74)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Paul C. Lott ORCID,Katherine Chiu,Juanita Elizabeth Quino ORCID,April Pangia Vang,Michael W. Lloyd ORCID

Live enrichment

PubMed:26207759 OpenAlex:https://openalex.org/W4307355776

National Institutes of Health

Grant: 3U54CA224083-04S1

Washington University PDX Development and Trial Center - Evaluation of Abemaciclib in Combination with Olaparib in Ovarian Cancer and Breast Cancer Patient-derived Xenograft Models

National Institutes of Health

Grant: 3U54CA224070-04S2

Rational approaches to melanoma therapy (PDXNet Administrative Supplement to R01CA241148)

National Institutes of Health

Grant: 5R01CA223978-04

Genetic studies of homologous recombination deficiency in hispanic gastric cancer

National Institutes of Health

Grant: 5U24CA224067-06

PDXNet Data Commons and Coordinating Center

National Institutes of Health

Grant: 1U54CA224065-01

University of Texas PDX Development and Trial Center

National Institutes of Health

Grant: 1R21CA199631-01A1

Dissecting gastric cancer clonality with genomic analyses and patient xenografts

National Institutes of Health

Grant: 3U54CA224076-01S2

PDX Trial Center for Breast Cancer Therapy

National Institutes of Health

Grant: 3P30CA093373-07S2

Cancer Center Support Grant - P30

National Institutes of Health

Grant: 5UL1TR001860-10

UC Davis Clinical and Translational Science Center

National Institutes of Health

Grant: 3U54CA283766-02S1

The role of ARID1A mutations in Latino gastric cancer biology and disparities

National Institutes of Health

Grant: 3U54CA233223-01S1

Minority PDX Development and Trial Center: Baylor College of Medicine and MD Anderson Cancer Center Collaboration on Mechanistic Studies to Dissect and Combat Health Disparities in Cancer

European Commission

Grant: 224067

Field Operational Tests of Aftermarket and Nomadic Devices in Vehicles

National Institutes of Health

Grant: 1U54CA233306-01

University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2022/10/25/2022.10.24.513591.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.10.24.513591

repositoryhttps://doi.org/10.1101/2022.10.24.513591

https://doi.org/10.1158/2767-9764.crc-23-0417

Fields of Study

Cancer Genomics and DiagnosticsMolecular Biology Techniques and ApplicationsGenetic factors in colorectal cancer0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Health equityContext (archaeology)Personalized medicinePrecision medicineEquity (law)Ethnic groupCancerMedicineDemographicsDiversity (politics)GerontologyDemographyPublic healthBioinformaticsPolitical scienceGeographyBiologyInternal medicinePathologySociologySocial Determinants of HealthHealth Disparities (rcdc)3105 Genetics (for-2020)MicePrecision Medicine (rcdc)NeoplasmsAnimals (mesh)Minority Health32 Biomedical and Clinical Sciences (for-2020)42 Health Sciences (for-2020)Cancer (rcdc)Humans (mesh)Neoplasms (mesh)3 Good Health and Well Being (sdg)JGMMice (mesh)GenomicsBiological SciencesHealth Disparities4203 Health Services and Systems (for-2020)Minority Health (rcdc)United States (mesh)Research ArticleNational Cancer Institute (U.S.) (mesh)610Social Determinants of Health (rcdc)Cancer GenomicsXenograft Model Antitumor Assays (mesh)Health Services and SystemsHealth SciencesGeneticsHumansAnimalsJMG31 Biological Sciences (for-2020)Biomedical and Clinical SciencesGenetics (rcdc)Human GenomeCancer (hrcs-hc)Human Genome (rcdc)Xenograft Model Antitumor AssaysUnited StatesNational Cancer Institute (U.S.)Good Health and Well BeingGenomics (mesh)Precision Medicine (mesh)PDXNet ConsortiumCancer Genomics (rcdc)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Partnerships for the goals